Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

IDH1 mutation + FGFR2 rearrangement

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

IDH1 mutation + Chr del(1p) + Chr del(19q) (10)

IDH1 mutation + BRAF V600E (2)

IDH1 mutation + Chr del(1p) + Chr del(19q) + BRAF V600E (2)

IDH1 mutation + Chr del(1p) + Chr del(19q) + NTRK1 fusion (2)

IDH1 mutation + Chr del(1p) + Chr del(19q) + NTRK2 fusion (2)

IDH1 mutation + Chr del(1p) + Chr del(19q) + NTRK3 fusion (2)

IDH1 mutation + NTRK1 fusion (2)

IDH1 mutation + NTRK2 fusion (2)

IDH1 mutation + NTRK3 fusion (2)

MYC overexpression + IDH1 mutation (2)

BAP1 mutation + FGFR2 fusion (1)

FGFR2 underexpression + FGFR3 mutation (1)

IDH1 mutation + FGFR2 fusion (1)

NOTCH1 positive + FGFR2 mutation (1)

PBRM1 mutation + FGFR2 fusion (1)

TP53 mutation + FGFR2 fusion (1)

IDH wild-type + FGFR3 S249C + TP53 V73fs (1)

IDH1 R132S + H3K27me3 loss + MET exon 14 skipping mutation (1)

IDH1 mutation + ATRX deletion + TP53 deletion (1)

IDH1 mutation + MGMT promoter methylation (1)

IDH1 mutation + MYC amplification + MAPRE1 overexpression (1)

IDH1 mutation + TMB-L (1)

IDH1 mutation + WT1 overexpression (1)

FGFR2 K660N + TP53 deletion (0)

IDH1 mutation + Chr del(1p) + Chr del(19q) + MGMT promoter methylation (0)

IDH1 mutation + Chr del(1p) + Chr del(19q) (10)

IDH1 mutation + BRAF V600E (2)

IDH1 mutation + Chr del(1p) + Chr del(19q) + BRAF V600E (2)

IDH1 mutation + Chr del(1p) + Chr del(19q) + NTRK1 fusion (2)

IDH1 mutation + Chr del(1p) + Chr del(19q) + NTRK2 fusion (2)

IDH1 mutation + Chr del(1p) + Chr del(19q) + NTRK3 fusion (2)

IDH1 mutation + NTRK1 fusion (2)

IDH1 mutation + NTRK2 fusion (2)

IDH1 mutation + NTRK3 fusion (2)

MYC overexpression + IDH1 mutation (2)

BAP1 mutation + FGFR2 fusion (1)

FGFR2 underexpression + FGFR3 mutation (1)

IDH1 mutation + FGFR2 fusion (1)

NOTCH1 positive + FGFR2 mutation (1)

PBRM1 mutation + FGFR2 fusion (1)

TP53 mutation + FGFR2 fusion (1)

IDH wild-type + FGFR3 S249C + TP53 V73fs (1)

IDH1 R132S + H3K27me3 loss + MET exon 14 skipping mutation (1)

IDH1 mutation + ATRX deletion + TP53 deletion (1)

IDH1 mutation + MGMT promoter methylation (1)

IDH1 mutation + MYC amplification + MAPRE1 overexpression (1)

IDH1 mutation + TMB-L (1)

IDH1 mutation + WT1 overexpression (1)

FGFR2 K660N + TP53 deletion (0)

IDH1 mutation + Chr del(1p) + Chr del(19q) + MGMT promoter methylation (0)

›

IDH1 mutation + FGFR2 rearrangement

Cholangiocarcinoma

Sensitive: C3 – Early Trials

Sensitive: C3 – Early Trials